Company news
Trailbreaker Resources Ltd (TSXV:TBK) news
Trailbreaker Resources Ltd news releases on 6ix. Latest, May 4, 2006: Axcan announces record revenue of $72.8 million for the second quarter of fiscal 2006
Press releases — page 4
Axcan announces record revenue of $72.8 million for the second quarter of fiscal 2006
May 4, 2006
Axcan Pharma's President and CEO to provide Keynote Luncheon Speech at AMBAQ's Annual MBA Conference April 27, 2006
April 26, 2006
Axcan announces conference call and web cast for second quarter of fiscal 2006 results
April 24, 2006
Axcan Pharma to present at the Scotia Capital Pharmaceutical & Biotechnology Conference
April 19, 2006
Axcan Pharma to present at the UBS Global Specialty Pharmaceuticals Conference
April 18, 2006
Axcan submits FDA amendment to its new drug application for HELIZIDE
March 29, 2006
Axcan Pharma to present at CIBC World Markets Biotechnology & Specialty Pharmaceuticals Conference
March 28, 2006
Axcan announces outcome of ITAX International Phase III clinical trial
February 22, 2006
Axcan Pharma to hold Annual and Special Meeting of Shareholders February 22, 2006
February 20, 2006
Axcan announces conference call on statistical approach for Phase III trials of ITAX
February 13, 2006
Axcan announces record revenue of $70.6 million for the first quarter of fiscal 2006
February 9, 2006
Axcan Pharma to present at CIBC's Institutional Investor Conference
February 8, 2006
Axcan announces conference call and web cast for first quarter of fiscal 2006 results
February 2, 2006
Axcan Pharma to present at Merrill Lynch Global Healthcare Conference
January 31, 2006
Axcan Appoints Steve Gannon Senior Vice President and Chief Financial Officer
January 20, 2006
Axcan Pharma to present at JP Morgan's Healthcare Conference
January 4, 2006
Axcan Exceeds Patient Randomization Target Necessary for Completion of North American ITAX (Itopride) Phase III Trial - Company is on Track for NDA Filing in the Summer of 2006
December 15, 2005
Axcan reports fourth quarter and year-end 2005 financial results - Company generates record revenues of $67.0 million for the quarter
November 10, 2005
Axcan Pharma to present at Credit Suisse First Boston's Healthcare Conference
November 9, 2005
Axcan announces conference call and web cast for fourth quarter and fiscal 2005 results
November 3, 2005
Axcan Pharma to Present at CIBC's 16th Annual Healthcare Conference
October 28, 2005
Axcan Pharma to present at the UBS Global Life Sciences Conference
September 22, 2005
Photofrin PDT reduces esophageal cancer occurrence in patients with Barrett's High Grade Dysplasia - Results of a 5-year follow-up study
September 13, 2005
Market Regulation Services - Trade Resumption - Axcan Pharma Inc - AXP
August 12, 2005
Axcan announces third quarter 2005 results
August 11, 2005
Axcan Pharma to present at the Orion Securities 10th annual healthcare conference
August 9, 2005
Axcan announces conference call and webcast for third quarter of fiscal 2005 results
August 2, 2005
More than 1000 patients enrolled in Axcan's ITAX Phase III functional dyspepsia studies
June 9, 2005
Axcan Pharma to present at the Merrill Lynch Canada 12th Annual Growth Stock Conference in Toronto
June 8, 2005
Axcan Pharma to Present at UBS Global Specialty Pharmaceuticals Conference in New York City
May 18, 2005
Axcan reports second quarter 2005 results
May 4, 2005
Axcan announces Conference Call and Web cast for Second Quarter of Fiscal 2005 Results
April 27, 2005
Axcan Pharma to Present at Scotia Capital Pharmaceutical and Biotechnology Conference in Toronto
April 20, 2005